Koselugo

Advertisement

cGxPJobs Banner

Koselugo Secures US Approval, Advancing Targeted NF1 Care

Wilmington, Delaware, November 2025 AstraZeneca has announced that Koselugo (selumetinib) has received expanded FDA approval in the United States...

By cGxPwire Editor
November 20, 2025

Read More

Advertisement

cGxPJobs

Directory